Ceftazidime/Avibactam-Based Versus Polymyxin B-Based Therapeutic Regimens for the Treatment of Carbapenem-Resistant Klebsiella Pneumoniae Infection in Critically Ill Patients: A Retrospective Cohort Study.
Research Square (Research Square)（2022）
Key words
Ceftazidime/avibactam,Carbapenem-resistant Klebsiella pneumoniae,Polymyxin B,Critically ill patients,Mortality,Microbiological eradication,Safety,Combination therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined